REFERENCES
1. Brignole M, Moya A, de Lange FJ, et al. 2018 ESC Guidelines for the diagnosis and management of syncope. Eur Heart J.2018;39(21):1883-1948.
2. Sheldon R. Tilt table testing and implantable loop recorders for syncope. Cardiology clinics. 2013;31(1):67-74.
3. Sheldon R, Rose S, Connolly S, Ritchie D, Koshman ML, Frenneaux M. Diagnostic criteria for vasovagal syncope based on a quantitative history. Eur Heart J. 2006;27(3):344-350.
4. Sheldon R, Rose S, Koshman ML. Comparison of patients with syncope of unknown cause having negative or positive tilt-table tests. Am J Cardiol. 1997;80(5):581-585.
5. Grimm W, Degenhardt M, Hoffman J, Menz V, Wirths A, Maisch B. Syncope recurrence can better be predicted by history than by head-up tilt testing in untreated patients with suspected neurally mediated syncope.Eur Heart J. 1997;18(9):1465-1469.
6. Moya A, Brignole M, Menozzi C, et al. Mechanism of syncope in patients with isolated syncope and in patients with tilt-positive syncope. Circulation. 2001;104(11):1261-1267.
7. Mallat Z, Vicaut E, Sangare A, Verschueren J, Fontaine G, Frank R. Prediction of head-up tilt test result by analysis of early heart rate variations. Circulation. 1997;96(2):581-584.
8. Oh JH, Kim JS, Kwon HC, et al. Predictors of positive head-up tilt test in patients with suspected neurocardiogenic syncope or presyncope.Pacing Clin Electrophysiol. 2003;26(2 Pt 1):593-598.
9. Kazemi B, Haghjoo M, Arya A, Sadr-Ameli MA. Predictors of response to the head-up tilt test in patients with unexplained syncope or presyncope. Pacing Clin Electrophysiol. 2006;29(8):846-851.
10. Yiu D, Gieroba Z, Hall K, Mackintosh S, Russell A, Mangoni AA. An early drop in systolic blood pressure predicts a positive tilt table test in elderly patients with unexplained falls or syncope. Age and ageing. 2006;35(2):183-185.
11. Nilsson D, Sutton R, Melander O, Fedorowski A. Spontaneous vs nitroglycerin-induced vasovagal reflex on head-up tilt: Are there neuroendocrine differences? Heart Rhythm. 2016;13(8):1674-1678.
12. Buszko K, Kujawski S, Newton JL, Zalewski P. Hemodynamic Response to the Head-Up Tilt Test in Patients With Syncope as a Predictor of the Test Outcome: A Meta-Analysis Approach. Front Physiol.2019;10:184.
13. Ghariq M, Thijs RD, Bek LM, van Zwet EW, Benditt DG, van Dijk JG. A higher proportion of men than of women fainted in the phase without nitroglycerin in tilt-induced vasovagal syncope. Clin Auton Res.2020.
14. Kulkarni N, Mody P, Levine BD. Abolish the Tilt Table Test for the Workup of Syncope! Circulation. 2020;141(5):335-337.
15. van Dijk JG, Ghariq M, Kerkhof FI, et al. Novel Methods for Quantification of Vasodepression and Cardioinhibition During Tilt-Induced Vasovagal Syncope. Circ Res. 2020;127(5):e126-e138.
16. Jardine DL, Wieling W, Brignole M, Lenders JWM, Sutton R, Stewart J. The pathophysiology of the vasovagal response. Heart Rhythm.2018;15(6):921-929.
17. Sutton R, Brignole M. Twenty-eight years of research permit reinterpretation of tilt-testing: hypotensive susceptibility rather than diagnosis. Eur Heart J. 2014;35(33):2211-2212.
18. Bartoletti A, Alboni P, Ammirati F, et al. ’The Italian Protocol’: a simplified head-up tilt testing potentiated with oral nitroglycerin to assess patients with unexplained syncope. Europace.2000;2(4):339-342.
19. Eeftinck Schattenkerk DW, van Lieshout JJ, van den Meiracker AH, et al. Nexfin noninvasive continuous blood pressure validated against Riva-Rocci/Korotkoff. Am J Hypertens. 2009;22(4):378-383.
20. Langewouters GJ, Settels JJ, Roelandt R, Wesseling KH. Why use Finapres or Portapres rather than intra-arterial or intermittent non-invasive techniques of blood pressure measurement? J Med Eng Technol. 1998;22(1):37-43.
21. Torabi P, Ricci F, Hamrefors V, et al. Impact of Cardiovascular Neurohormones on Onset of Vasovagal Syncope Induced by Head-up Tilt.Journal of the American Heart Association. 2019;8(12):e012559.
22. Kohno R, Detloff BLS, Chen LY, Norby FL, Benditt DG. Greater early epinephrine rise with head-up posture: A marker of increased syncope susceptibility in vasovagal fainters. J Cardiovasc Electrophysiol. 2019;30(3):289-296.
23. Lindenberger M, Fedorowski A, Melander O, Gallo W, Engvall J, Skoog J. Cardiovascular biomarkers and echocardiographic findings at rest and during graded hypovolemic stress in women with recurrent vasovagal syncope. J Cardiovasc Electrophysiol. 2019;30(12):2936-2943.
24. Alboni P, Alboni M. Typical vasovagal syncope as a ”defense mechanism” for the heart by contrasting sympathetic overactivity.Clin Auton Res. 2017;27(4):253-261.
25. Blanc JJ, Alboni P, Benditt DG. Vasovagal syncope in humans and protective reactions in animals. Europace. 2015;17(3):345-349.
26. Bachus E, Holm H, Hamrefors V, et al. Monitoring of cerebral oximetry during head-up tilt test in adults with history of syncope and orthostatic intolerance. Europace. 2018;20(9):1535-1542.
27. Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J.2018;39(33):3021-3104.